Sun Pharma says USFDA denies approval to sell epilepsy drug
India`s Sun Pharma Advanced Research Company Ltd (SPARC) said the U.S. Food and Drug Administration has denied its application for approval to launch a new anti-epilepsy drug, citing manufacturing quality issues at its production site.
Sep 26, 2015, 12:36 PM IST
SPARC licenses Xelpros to Sun Pharma for US market
Sun Pharma Advanced Research Company (SPARC) has licensed out Xelpros, a preservative-free eye drop, to a subsidiary of Sun Pharma for the US market.
Jun 09, 2015, 23:25 PM IST
SPARC shares surge 15%; m-cap up by Rs 1,685 cr
Stocks of Sun Pharma Advanced Research Company surged 15 percent Monday after the company received approval from the US health regulator for a New Drug Application (NDA).
Mar 09, 2015, 18:05 PM IST
